Categorie -wet- en regelgeving

bv CGR, GDPR

wet- en regelgeving

European approval for Skyrizi, hot on the heels of US

1 mei 2019

PMLiVE

wet- en regelgeving

FDA refuses to review Nabriva’s injectable antibiotic for urinary tract infections

1 mei 2019

InPharm.com

wet- en regelgeving

FDA approves AbbVie’s Mavyret for children with Hepatitis C (HCV)

1 mei 2019

InPharm.com

wet- en regelgeving

Sanofi and Lexicon’s Zynquista scores EU approval for type 1 diabetes patients

30 april 2019

InPharm.com

wet- en regelgeving

Bayer gains FDA priority review for prostate cancer drug

30 april 2019

PMLiVE

wet- en regelgeving

FDA approves new treatment for children with lupus

29 april 2019

News-Medical.Net

Medhc-fases-banner

Advertentie(s)

Copyright 2023 © Uitgave van MedHealth Communications BV | Privacy disclaimer